ANI Pharmaceuticals Inc (ANIP)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

210 MAIN STREET WEST BAUDETTE, MN 56623

BioSante Pharmaceuticals is a pharmaceutical company focused on developing products for female sexual health and oncology. Co.'s products for female sexual health, menopause, contraception and male hypogonadi® include its gel formulations of estradiol or testosterone and combinations of estrogen, progestogen and androgen. Co.'s products, either approved or in human clinical development, include LibiGel, a once daily transdermal testosterone gel; a male testosterone gel; GVAX cancer vaccines; the Pill-Plus, a once daily use of various combinations of estrogens, progestogens and androgens; as well as Elestrin, a once daily transdermal estradiol (estrogen) gel.

Data based on most recent fiscal year report
Market Cap668.235 Million Shares Outstanding11.66 Million Avg Volume213.483 Thousand
1-Yr BETA vs S&P TR0.809 Current Ratio3.35 Quick Ratio2.39
View SEC Filings from ANIP instead.
Q1 2019 All Institutions Hedge Funds 1
To trade ANIP now:
Filers who had this stock in their top 10: 2 1 (0.1%)
13F Filers holding this stock: 186 24 (2.45%)
Aggregate 13F shares on 03/31/2019: 7.696 Million 1.513 Million
Aggregate 13F shares on 12/31/2018: 7.081 Million 1.411 Million
Percent change: 8.68% 7.27%
Funds creating new positions: 36 6
Funds Adding to an existing position: 57 5
Funds closing out their position: 15 3
Funds reducing their position: 54 9
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ANIP (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

2.5 Thousand total shares from 1 transactions

Open Market Sells (S)

46.2 Thousand total shares from 6 transactions

Exercise Derivative Conversion (M)

2.2 Thousand total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SHERWIN STEPHEN A

  • Director
0 2019-05-22 0

MARKEN JAMES G. SVP OPS & PROD DEV

  • Officer
61,230 2019-05-17 6

BROWN ROBERT E. JR

  • Director
22,561 2019-05-16 3

HAUGHEY THOMAS

  • Director
6,291 2019-05-15 3

SCHREPFER ROBERT W SVP - NEW BUS DEV & SPEC SALES

  • Officer
55,927 2019-05-13 7

PRZYBYL ARTHUR PRESIDENT AND CEO

  • Officer
  • Director
202,589 2019-05-13 6

SULLIVAN LOUIS W

  • Director
54,730 2019-05-07 0

NASH DAVID

  • Director
118 2019-04-18 2

CAREY STEPHEN P. VICE PRESIDENT AND CFO

  • Officer
25,450 2019-04-06 3

PENN THOMAS A.

  • Director
14,301 2019-03-28 2

WALSH PATRICK D

  • Director
3,791 2019-03-28 2

DONENBERG PHILLIP B. SVP AND CFO

  • Officer
0 2018-07-16 0

MARSHBANKS TRACY

  • Director
349,934 2018-05-14 0

HOLUBOW FRED

  • Director
14,811 2018-03-20 0

RAYNOR DANIEL

  • Director
289,003 2018-03-15 0

POTTS JOHN T JR

  • Director
159,253 2017-06-09 0

ARNOLD CHARLOTTE C. VICE PRESIDENT AND CFO

  • Officer
54,298 2016-04-07 0

LANKAU PETER A

  • Director
2,500 2016-04-07 0

MERIDIAN VENTURE PARTNERS II LP

MERIDIAN VENTURE PARTNERS II GP, L.P.

MERIDIAN VENTURE PARTNERS II, CO.

BROWN ROBERT E. JR

  • Director
  • 10% Owner
2,350,559 2015-03-12 0

MANGANO ROSS J

  • Director
26,914 2014-09-15 0

SIMES STEPHEN M CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2014-07-24 0

JAMNICK ROBERT J. VP, QUALITY & PRODUCT DEVELOP.

  • Officer
48,118 2014-05-22 0

BROWN ROBERT E. JR

PENN THOMAS A.

  • Director
  • 10% Owner
16,918,469 2013-06-19 0

MERIDIAN VENTURE PARTNERS II LP

MERIDIAN VENTURE PARTNERS II GP, L.P.

MERIDIAN VENTURE PARTNERS II, CO.

  • 10% Owner
16,918,469 2013-06-19 0

ROSENOW EDWARD C III

  • Director
20,540 2012-03-30 0

SNABES MICHAEL C SR. VP OF MEDICAL AFFAIRS

  • Officer
0 2012-01-25 0

KJAER PETER

  • Director
34,425 2010-03-31 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

MARKEN JAMES G. - Officer SVP OPS & PROD DEV

2019-05-17 S 8,907 $70.67 d 61,230 61,230.00 direct

BROWN ROBERT E. JR - Director

2019-05-16 M 1,042 d 0 22,561.00 direct

BROWN ROBERT E. JR - Director

2019-05-16 M 1,167 $33.00 a 22,561 22,561.00 direct

BROWN ROBERT E. JR - Director

2019-05-16 M 1,167 d 0 22,561.00 direct

BROWN ROBERT E. JR - Director

2019-05-16 M 1,042 $6.36 a 21,394 22,561.00 direct

PRZYBYL ARTHUR - Director - Officer PRESIDENT AND CEO

2019-05-15 S 14,633 $69.25 d 202,589 202,589.00 direct

HAUGHEY THOMAS - Director

2019-05-15 P 2,500 $69.30 a 6,291 6,291.00 direct

PRZYBYL ARTHUR - Director - Officer PRESIDENT AND CEO

2019-05-14 S 5,772 $70.45 d 217,222 202,589.00 direct

MARKEN JAMES G. - Officer SVP OPS & PROD DEV

2019-05-14 S 4,917 $70.31 d 70,137 70,137.00 direct

SCHREPFER ROBERT W - Officer SVP - NEW BUS DEV & SPEC SALES

2019-05-13 S 2,409 $71.13 d 55,927 55,927.00 direct

PRZYBYL ARTHUR - Director - Officer PRESIDENT AND CEO

2019-05-13 S 9,595 $71.10 d 222,994 202,589.00 direct

SCHREPFER ROBERT W - Officer SVP - NEW BUS DEV & SPEC SALES

2019-04-16 F 360 $68.60 d 58,336 58,336.00 direct

MARKEN JAMES G. - Officer SVP OPS & PROD DEV

2019-04-16 F 115 $68.60 d 75,054 75,054.00 direct

PRZYBYL ARTHUR - Director - Officer PRESIDENT AND CEO

2019-04-16 F 1,692 $68.60 d 232,589 232,589.00 direct

PRZYBYL ARTHUR - Director - Officer PRESIDENT AND CEO

2019-04-07 F 2,115 $70.50 d 234,281 234,281.00 direct

SCHREPFER ROBERT W - Officer SVP - NEW BUS DEV & SPEC SALES

2019-04-07 F 392 $70.50 d 58,696 58,696.00 direct

MARKEN JAMES G. - Officer SVP OPS & PROD DEV

2019-04-07 F 144 $70.50 d 75,169 75,169.00 direct

PRZYBYL ARTHUR - Director - Officer PRESIDENT AND CEO

2019-04-06 F 3,282 $70.50 d 236,396 234,281.00 direct

SCHREPFER ROBERT W - Officer SVP - NEW BUS DEV & SPEC SALES

2019-04-06 F 659 $70.50 d 59,088 58,696.00 direct

MARKEN JAMES G. - Officer SVP OPS & PROD DEV

2019-04-06 F 337 $70.50 d 75,313 75,169.00 direct

CAREY STEPHEN P. - Officer VICE PRESIDENT AND CFO

2019-04-06 F 612 $70.50 d 25,450 25,450.00 direct

MARKEN JAMES G. - Officer SVP OPS & PROD DEV

2019-03-31 F 278 $70.54 d 75,650 75,650.00 direct

PRZYBYL ARTHUR - Director - Officer PRESIDENT AND CEO

2019-03-31 F 2,678 $70.54 d 239,678 239,678.00 direct

SCHREPFER ROBERT W - Officer SVP - NEW BUS DEV & SPEC SALES

2019-03-31 F 546 $70.54 d 59,747 59,747.00 direct

CAREY STEPHEN P. - Officer VICE PRESIDENT AND CFO

2019-03-31 F 507 $70.54 d 26,062 26,062.00 direct

PENN THOMAS A. - Director

2019-03-28 A 1,991 a 14,301 14,301.00 direct

WALSH PATRICK D - Director

2019-03-28 A 2,409 a 2,409 3,791.00 direct

NASH DAVID - Director

2019-03-28 A 1,991 a 3,791 3,791.00 direct

PRZYBYL ARTHUR - Director - Officer PRESIDENT AND CEO

2019-03-28 A 45,106 a 45,106 242,356.00 direct

CAREY STEPHEN P. - Officer VICE PRESIDENT AND CFO

2019-03-28 A 12,451 a 26,569 26,569.00 direct

BROWN ROBERT E. JR - Director

2019-03-28 A 3,127 a 3,127 20,352.00 direct

SCHREPFER ROBERT W - Officer SVP - NEW BUS DEV & SPEC SALES

2019-03-28 A 12,451 a 60,293 60,293.00 direct

WALSH PATRICK D - Director

2019-03-28 A 1,991 a 3,791 3,791.00 direct

MARKEN JAMES G. - Officer SVP OPS & PROD DEV

2019-03-28 A 8,285 a 8,285 75,928.00 direct

PRZYBYL ARTHUR - Director - Officer PRESIDENT AND CEO

2019-03-28 A 37,280 a 242,356 242,356.00 direct

HAUGHEY THOMAS - Director

2019-03-28 A 2,409 a 2,409 3,791.00 direct

BROWN ROBERT E. JR - Director

2019-03-28 A 2,584 a 20,352 20,352.00 direct

PENN THOMAS A. - Director

2019-03-28 A 2,409 a 2,409 14,301.00 direct

NASH DAVID - Director

2019-03-28 A 2,409 a 2,409 3,791.00 direct

MARKEN JAMES G. - Officer SVP OPS & PROD DEV

2019-03-28 A 6,848 a 75,928 75,928.00 direct

CAREY STEPHEN P. - Officer VICE PRESIDENT AND CFO

2019-03-28 A 15,064 a 15,064 26,569.00 direct

HAUGHEY THOMAS - Director

2019-03-28 A 1,991 a 3,791 3,791.00 direct

SCHREPFER ROBERT W - Officer SVP - NEW BUS DEV & SPEC SALES

2019-03-28 A 15,064 a 15,064 60,293.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments